THORELL MARELLA (Chief Financial Officer) sold 7.5% of their position (1.81K shares) of EVELO BIOSCIENCES, INC. on the open market
Open‑market sale worth $597.63 — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/8/2023ACC: 0001694665-23-000175
Officer· Chief Financial Officer
Since Jul 2022
-1.81K
Net shares
Net seller
$597.63
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.50K acquired · 8.31K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.50K
Price / share
—
Trade value
—
% of position
37.0%
11/7/2023
17.57K→24.07K
Common Stock
Direct
Shares
−1.81K
Price / share
$0.33
Trade value
$597.63
% of position
7.5%
11/8/2023
24.07K→22.26K
Total
Net shares
+4.69K
Net value
-$597.63
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/7/2023 | M · Option Exercise | +6.50K | — | — | 37.0% | 17.57K | 24.07K |
| Common Stock Direct | 11/8/2023 | S · Sale | −1.81K | $0.33 | $597.63 | 7.5% | 24.07K | 22.26K |
| Total | +4.69K | -$597.63 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
6.50K shares
Shares
−6.50K
Strike price
Held after
6.50K
Exercisable
—
11/7/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock6.50K shares | 11/7/2023 | M · Option Exercise | −6.50K | — | 6.50K |